Advachemlabsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-07-19
Share capital
250,000.00 PLN
Registered address
Topazowa 8, 61-680 Poznań, Poland
Electronic delivery address
AE:PL-95464-19134-JSGDU-16

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 103 days for 2021).

  • 2024not filed
  • 202316/07/2024
  • 202211/09/2023
  • 202126/10/2022
  • 202009/06/2021
  • 201915/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue
This companyUSD 142.87kMedianUSD 178.92kAverageUSD 6.85m
Net profit
This companyUSD 55.51kMedianUSD 2.73kAverageUSD 464.86k
Operating costs
This companyUSD 87.32kMedianUSD 175.18kAverageUSD 6.09m
Assets
This companyUSD 600.41kMedianUSD 160.35kAverageUSD 5.64m

Authorized Representatives

Tomasz Grabarkiewicz – President of the Management Board

Manner of representation

- The President of the Management Board acting jointly with another member of the management board; - in the case of a one-person management board, the President of the Management Board independently.

Supervisory board

Krzysztof Tomasz Grabarkiewicz – Supervisory Board Member
Marcin Maciej Hoffmann – Supervisory Board Member
Leszek Rychlewski – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Patrycja Dykasage 30
2,000$54,024.8580%
Tomasz Grabarkiewiczage 49
500$13,506.2120%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2007-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $220,772.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$56,708
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$81,475
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$81,795

European Funds

ProjectEU co-financing
Quinine bark alkaloid conjugates as new lead compounds in the pharmacotherapy of cancer (ONCO)
$56,708
Development of an innovative biological preparation to protect cereal seeds from feeding animals
$81,795
Development of a new, efficient and economical technology for synthesising cinchona alkaloid derivatives (organocatalysts and precursors for the synthesis of drugs, active substances and highly processed chemicals)
$45,041

Competitors

Name
Procosmetica sp. z o.o.sp. k.
Mexmosp. z o.o.
IMU MedicalS.A.
Mycode Beautysp. z o.o.
Eryngiumsp. z o.o.
Pcschemiasp. z o.o.
GLOEsp. z o.o.
Sunewmed+sp. z o.o.
Sunewlab+sp. z o.o.
Pipilashessp. z o.o.

Change history

DateEvent
2008-09-12Share capital increase
2008-09-12Switch to PKD 2007
2008-05-29Share capital reduction
2007-11-13Share capital increase
2007-07-19Entered in the register

FAQ

Last updated: 2026-04-14